Zawada M - Search Results

1

IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.

Libura M, Bialopiotrowicz E, Giebel S, Wierzbowska A, Roboz GJ, Piatkowska-Jakubas B, Pawelczyk M, Gorniak P, Borg K, Wojtas M, Florek I, Matiakowska K, Jazwiec B, Solarska I, Noyszewska-Kania M, Piechna K, Zawada M, Czekalska S, Salamanczuk Z, Karabin K, Wasilewska K, Paluszewska M, Urbanowska E, Gajkowska-Kulik J, Semenczuk G, Rybka J, Wrobel T, Ejduk A, Kata D, Grosicki S, Robak T, Pluta A, Kominek A, Piwocka K, Pyziak K, Sroka-Porada A, Wrobel A, Przybylowicz A, Wojtaszewska M, Lewandowski K, Gil L, Piekarska A, Knopinska W, Bolkun L, Warzocha K, Kuliczkowski K, Sacha T, Basak G, Jedrzejczak WW, Holowiecki J, Juszczynski P, Haus O. Libura M, et al. Among authors: zawada m. Sci Rep. 2021 May 11;11(1):10017. doi: 10.1038/s41598-021-88120-y. Sci Rep. 2021. PMID: 33976256 Free PMC article.

2

Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.

Libura M, Giebel S, Piatkowska-Jakubas B, Pawelczyk M, Florek I, Matiakowska K, Jazwiec B, Borg K, Solarska I, Zawada M, Czekalska S, Libura J, Jakobczyk M, Karabin K, Paluszewska M, Calbecka M, Gajkowska-Kulik J, Gadomska G, Kielbinski M, Ejduk A, Kata D, Grosicki S, Wierzbowska A, Kyrcz-Krzemien S, Warzocha K, Kuliczkowski K, Skotnicki A, Holowiecki J, Jedrzejczak WW, Haus O. Libura M, et al. Among authors: zawada m. Blood. 2016 Jan 21;127(3):360-2. doi: 10.1182/blood-2015-08-662130. Epub 2015 Nov 13. Blood. 2016. PMID: 26567156 Free article. No abstract available.

3

CEBPA copy number variations in normal karyotype acute myeloid leukemia: Possible role of breakpoint-associated microhomology and chromatin status in CEBPA mutagenesis.

Libura M, Pawełczyk M, Florek I, Matiakowska K, Jaźwiec B, Borg K, Solarska I, Zawada M, Czekalska S, Libura J, Salamanczuk Z, Jakóbczyk M, Mucha B, Duszeńko E, Soszyńska K, Karabin K, Piątkowska-Jakubas B, Całbecka M, Gajkowska-Kulig J, Gadomska G, Kiełbiński M, Ejduk A, Kata D, Grosicki S, Kyrcz-Krzemień S, Warzocha K, Kuliczkowski K, Skotnicki A, Jęrzejczak WW, Haus O. Libura M, et al. Among authors: zawada m. Blood Cells Mol Dis. 2015 Dec;55(4):284-92. doi: 10.1016/j.bcmd.2015.07.002. Epub 2015 Jul 7. Blood Cells Mol Dis. 2015. PMID: 26460249

4

Wilms' tumor gene 1 expression analysis by real-time quantitative polymerase chain reaction for monitoring of minimal residual disease in acute leukemia.

Nowakowska-Kopera A, Sacha T, Florek I, Zawada M, Czekalska S, Skotnicki AB. Nowakowska-Kopera A, et al. Among authors: zawada m. Leuk Lymphoma. 2009 Aug;50(8):1326-32. doi: 10.1080/10428190903050021. Leuk Lymphoma. 2009. PMID: 19811333

5

Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience.

Szczepanek E, Chukwu O, Kamińska M, Wysogląd H, Cenda A, Zawada M, Jakóbczyk M, Wącław J, Sacha T. Szczepanek E, et al. Among authors: zawada m. Leuk Lymphoma. 2022 Sep;63(9):2213-2223. doi: 10.1080/10428194.2022.2068000. Epub 2022 May 2. Leuk Lymphoma. 2022. PMID: 35491715

6

A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs.

Link-Lenczowska D, Pallisgaard N, Cordua S, Zawada M, Czekalska S, Krochmalczyk D, Kanduła Z, Sacha T. Link-Lenczowska D, et al. Among authors: zawada m. Ann Hematol. 2018 Dec;97(12):2299-2308. doi: 10.1007/s00277-018-3451-1. Epub 2018 Jul 28. Ann Hematol. 2018. PMID: 30056580 Free PMC article. Clinical Trial.

7

[Standardization of quantitative detection of BCR-ABL gene expression by RQ-PCR in patients with chronic myeloid leukemia in cooperation with European Leukemia Net].

Sacha T, Zawada M, Czekalska S, Florek I, Mueller M, Gniot M, Jaźwiec B, Kyrcz-Krzemień S, Leszczyńska A, Lewandowski K, Matiakowska K, Solarska I, Stokłosa T, Skotnicki AB. Sacha T, et al. Among authors: zawada m. Przegl Lek. 2010;67(7):454-9. Przegl Lek. 2010. PMID: 21387754 Polish.

8

[Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)--single center].

Czekalska S, Sacha T, Piatkowska-Jakubas B, Zawada M, Florek I, Cwynar D, Skotnicki AB. Czekalska S, et al. Among authors: zawada m. Przegl Lek. 2010;67(12):1282-91. Przegl Lek. 2010. PMID: 21591354 Polish.

9

[ABL domain kinase point mutations as a cause of resistance to therapy of patients with chronic myeloid leukemia with tyrosine kinase inhibitors. Single center experience].

Sacha T, Foryciarz K, Florek I, Zawada M, Czekalska S, Cwynar D, Pecek E, Skotnicki AB. Sacha T, et al. Among authors: zawada m. Przegl Lek. 2011;68(5):253-7. Przegl Lek. 2011. PMID: 21961412 Polish.

10

[Implementation of direct sequencing as a method of ABL gene mutations analysis in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor].

Florek I, Sacha T, Zawada M, Czekalska S, Foryciarz K, Cwynar D, Pecek E, Skotnicki AB. Florek I, et al. Among authors: zawada m. Przegl Lek. 2010;67(12):1292-7. Przegl Lek. 2010. PMID: 21591355 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page